Evidence map›Paper›PMID 42837053›Full record

ArticleHead and neck pathology2026

Pediatric and Adult Sinonasal Phosphaturic Mesenchymal Tumors: CDKN2A Copy Number Alterations and Their Association with Recurrence.

Kavneet Kaur, Shreya Ojha, Kirti Srivastava, Hitesh Verma, Rajeev Kumar, Rakesh Kumar, Alok Thakar, Shipra Agarwal, Aanchal Kakkar, Ashu Seith Bhalla and 1 more

Abstract read
In one paragraph

Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kavneet KaurDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. dockavneetkaur@gmail.com.ORCID http://orcid.org/0000-0002-6716-3002
Shreya OjhaDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Kirti SrivastavaDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Hitesh VermaDepartment of Otorhinolaryngology-Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Rajeev KumarDepartment of Otorhinolaryngology-Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Rakesh KumarDepartment of Otorhinolaryngology-Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Alok ThakarDepartment of Otorhinolaryngology-Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Shipra AgarwalDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Aanchal KakkarDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Ashu Seith BhallaDepartment of Radiodiagnosis, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Deepali JainDepartment of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePhosphaturic mesenchymal tumors (PMTs) are exceptionally rare neoplasms that secrete fibroblast growth factor 23 (FGF23), leading to tumor-induced osteomalacia (TIO). Owing to their nonspecific clinical manifestations and deceptively bland morphology, diagnosis is frequently delayed unless there is a high index of clinical suspicion or recognition of characteristic histopathological features. While PMTs predominantly arise in the appendicular skeleton, involvement of the sinonasal tract is uncommon, and pediatric sinonasal PMTs have not been reported previously. Although most PMTs follow a benign course, a subset demonstrates local recurrence, and predictors of recurrence remain poorly defined. METHODS AND MATERIALS: All cases of sinonasal PMTs diagnosed at our institution over a 10-year period were retrospectively reviewed. Clinical, radiological, histopathological, immunohistochemical, and molecular findings were analyzed. Immunohistochemistry was performed for SATB2, ERG, SMA, CD56, desmin, SSTR2, SSTR5, FGFR1, and Ki-67. Fluorescence in situ hybridization (FISH) was performed using FGFR1 dual-color break-apart and CDKN2A/CEP9 dual-color locus-specific probes.

resultsSeven sinonasal PMTs were identified, including two pediatric cases (both 10-year-old females) and five adult cases (age range: 32-68 years; overall range: 10-68 years). Patients presented with non-specific symptoms, most commonly related to tumor-induced osteomalacia, while a minority presented with local sinonasal complaints. Histologically, all tumors were unencapsulated and composed of ovoid cells embedded within a characteristic pale eosinophilic stroma with prominent, often dilated vasculature. Adipose tissue was present in 6/7 (85.7%) cases, osteoclast-like giant cells and hemosiderin-laden macrophages in 4/7 (57.1%) each, whereas grungy calcification, osteoid-like matrix, and aneurysmal bone cyst-like areas were infrequent. Tumors showed diffuse expression of SATB2, ERG, SMA, CD56, and SSTR2, while FGFR1 immunohistochemistry lacked specificity. FGFR1 gene rearrangement was identified by FISH in two cases. Notably, both pediatric tumors demonstrated CDKN2A homozygous deletion and developed local recurrence, whereas none of the adult tumors showed CDKN2A loss or recurred.

conclusionSinonasal PMTs are rare neoplasms that pose significant diagnostic challenges because of their rarity and morphological overlap with other mesenchymal tumors. Recognition of their characteristic histological features, supported by an appropriate immunohistochemical panel and FGFR1 FISH, facilitates accurate diagnosis. This study represents the first report of pediatric sinonasal PMTs and identifies CDKN2A homozygous deletion as a potential marker of recurrent behavior, warranting further investigation in larger cohorts.

Indexed as

Cyclin-Dependent Kinase Inhibitor p16MesenchymomaNeoplasm Recurrence, LocalNeoplasms, Connective TissueParanasal Sinus NeoplasmsAdolescentAdultAgedBiomarkers, TumorChildDNA Copy Number VariationsFemaleFibroblast Growth Factor-23HumansMaleMiddle AgedBiomarkers, TumorCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16FGF23 protein, humanFibroblast Growth Factor-23CDKN2APediatricPhosphaturic mesenchymal tumorRecurrentSinonasal

Identifiers

PMID42837053
PMCPMC13642869

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.